These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1113 related articles for article (PubMed ID: 34520463)

  • 1. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
    PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
    PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial.
    Semitala FC; Chaisson LH; Dowdy DW; Armstrong DT; Opira B; Aman K; Kamya M; Phillips PPJ; Yoon C
    Trials; 2022 May; 23(1):399. PubMed ID: 35550621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
    Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
    BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
    de Siqueira-Filha NT; Legood R; Cavalcanti A; Santos AC
    Value Health; 2018 Apr; 21(4):482-490. PubMed ID: 29680106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New opportunities in tuberculosis prevention: implications for people living with HIV.
    González Fernández L; Casas EC; Singh S; Churchyard GJ; Brigden G; Gotuzzo E; Vandevelde W; Sahu S; Ahmedov S; Kamarulzaman A; Ponce-de-León A; Grinsztejn B; Swindells S
    J Int AIDS Soc; 2020 Jan; 23(1):e25438. PubMed ID: 31913556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of systematic screening for tuberculosis disease and tuberculosis preventive treatment among people living with HIV attending antiretroviral treatment clinics in Ghana: a national pilot study.
    Adusi-Poku Y; Addai L; Wadie B; Afutu FK; Bruce SAK; Baddoo NA; Wagaw ZA; Campbell JR; Merle CS; Frimpong Amenyo RP
    BMJ Open; 2024 May; 14(5):e083557. PubMed ID: 38806436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis preventive treatment uptake among adults living with human immunodeficiency virus: Analysis of Zimbabwe population-based human immunodeficiency virus impact assessment 2020.
    Maphosa T; Mirkovic K; Weber RA; Musuka G; Mapingure MP; Ershova J; Laws R; Dobbs T; Coggin W; Sandy C; Apollo T; Mugurungi O; Melchior M; Farahani MS
    Int J STD AIDS; 2024 Jul; 35(8):593-599. PubMed ID: 38515336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
    Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis.
    Roscoe C; Lockhart C; de Klerk M; Baughman A; Agolory S; Gawanab M; Menzies H; Jonas A; Salomo N; Taffa N; Lowrance D; Robsky K; Tollefson D; Pevzner E; Hamunime N; Mavhunga F; Mungunda H
    BMC Public Health; 2020 Dec; 20(1):1838. PubMed ID: 33261569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
    Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
    BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis.
    Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV
    J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.